Drug Shortage Report for MYCOBUTIN
| Report ID | 267808 |
| Drug Identification Number | 02063786 |
| Brand name | MYCOBUTIN |
| Common or Proper name | MYCOBUTIN |
| Company Name | PFIZER CANADA ULC |
| Market Status | MARKETED |
| Active Ingredient(s) | RIFABUTIN |
| Strength(s) | 150MG |
| Dosage form(s) | CAPSULE |
| Route of administration | ORAL ORAL |
| Packaging size | BOTTLE 100 |
| ATC code | J04AB |
| ATC description | DRUGS FOR TREATMENT OF TUBERCULOSIS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2026-01-09 |
| Actual start date | |
| Estimated end date | 2026-03-02 |
| Actual end date | |
| Shortage status | Anticipated shortage |
| Updated date | 2025-10-27 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | Yes |
| Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
| Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v7 | 2025-10-27 | English | Compare |
| v6 | 2025-10-16 | French | Compare |
| v5 | 2025-10-16 | English | Compare |
| v4 | 2025-10-02 | French | Compare |
| v3 | 2025-10-02 | English | Compare |
| v2 | 2025-09-25 | French | Compare |
| v1 | 2025-09-25 | English | Compare |
Showing 1 to 7 of 7